• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情时代的皮肤血管炎和血管病

Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.

作者信息

Maronese Carlo Alberto, Zelin Enrico, Avallone Gianluca, Moltrasio Chiara, Romagnuolo Maurizio, Ribero Simone, Quaglino Pietro, Marzano Angelo Valerio

机构信息

Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

出版信息

Front Med (Lausanne). 2022 Aug 23;9:996288. doi: 10.3389/fmed.2022.996288. eCollection 2022.

DOI:10.3389/fmed.2022.996288
PMID:36082274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445267/
Abstract

Cutaneous vasculitides encompass a heterogeneous group of clinicopathological entities, which may occur as single-organ vasculitis of the skin or present as skin-limited variant of systemic vasculitis (i.e., skin-limited ANCA-associated vasculitis), and are triggered by various factors, including infections, drugs and vaccines. The COVID-19 pandemic has challenged us with a variety of both disease- and vaccine-associated skin manifestations, including vasculitis. Among the latter, cutaneous small-vessel vasculitis, previously known as leukocytoclastic vasculitis, seems to be the most reported in either scenario, i.e., natural infection and vaccination. Vasculopathy without true vasculitic changes on histology develops in but a minority of cases, mostly severe/critical COVID-19 patients, and appears to be the result of endothelial injury due to pauci-immune thromboembolic mechanisms. Herein, we provide an overview of the available literature on COVID-19-associated and anti-SARS-CoV-2-vaccine-associated cutaneous vasculitis. Although evidence is mostly limited to isolated reports, with a proportion of cases lacking histopathological confirmation, ample overlap with pre-pandemic forms is shown.

摘要

皮肤血管炎包括一组临床病理特征各异的疾病,可表现为皮肤的单器官血管炎,或作为系统性血管炎的皮肤局限性变体(即皮肤局限性抗中性粒细胞胞浆抗体相关性血管炎)出现,并由多种因素引发,包括感染、药物和疫苗。新冠疫情给我们带来了各种与疾病和疫苗相关的皮肤表现,包括血管炎。在后者中,皮肤小血管炎,以前称为白细胞破碎性血管炎,似乎在自然感染和接种疫苗这两种情况下都是报道最多的。组织学上无真正血管炎改变的血管病变仅在少数病例中出现,大多为重症/危重症新冠患者,似乎是由寡免疫血栓栓塞机制导致的内皮损伤所致。在此,我们概述了关于新冠病毒相关和抗SARS-CoV-2疫苗相关皮肤血管炎的现有文献。尽管证据大多限于个别报道,部分病例缺乏组织病理学证实,但显示出与疫情前形式有大量重叠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/9445267/5d3ca5a2b214/fmed-09-996288-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/9445267/5d3ca5a2b214/fmed-09-996288-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/9445267/5d3ca5a2b214/fmed-09-996288-g0001.jpg

相似文献

1
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic.新冠疫情时代的皮肤血管炎和血管病
Front Med (Lausanne). 2022 Aug 23;9:996288. doi: 10.3389/fmed.2022.996288. eCollection 2022.
2
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells.COVID-19 血管炎和血管病变-从 II 型肺泡细胞和肺内皮细胞的紧密并置中出现的独特免疫病理学。
Semin Immunopathol. 2022 May;44(3):375-390. doi: 10.1007/s00281-022-00928-6. Epub 2022 Apr 12.
3
Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination.皮肤血管炎:来自COVID-19及COVID-19疫苗接种的经验教训
Front Med (Lausanne). 2022 Dec 9;9:1013846. doi: 10.3389/fmed.2022.1013846. eCollection 2022.
4
Clinical study on single-organ cutaneous small vessels vasculitis: a retrospective observational study.临床研究单器官皮肤小血管血管炎:回顾性观察研究。
Eur Rev Med Pharmacol Sci. 2024 Jan;28(2):534-541. doi: 10.26355/eurrev_202401_35051.
5
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.接种 COVID-19 疫苗后的白细胞碎裂性血管炎(皮肤小血管血管炎)。
J Autoimmun. 2022 Feb;127:102783. doi: 10.1016/j.jaut.2021.102783. Epub 2021 Dec 28.
6
SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review.SARS-CoV-2 疫苗接种诱导的皮肤血管炎:两例新病例报告及文献复习。
Dermatol Ther. 2022 Jun;35(6):e15458. doi: 10.1111/dth.15458. Epub 2022 Mar 25.
7
Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis.COVID-19 感染导致的皮肤白细胞碎裂性血管炎,继发广泛皮肤坏死。
Clin Dermatol. 2022 Jul-Aug;40(4):397-401. doi: 10.1016/j.clindermatol.2022.02.013. Epub 2022 Mar 4.
8
Skin involvement in cutaneous and systemic vasculitis.皮肤在皮肤和系统性血管炎中的表现。
Autoimmun Rev. 2013 Feb;12(4):467-76. doi: 10.1016/j.autrev.2012.08.005. Epub 2012 Aug 16.
9
SARS-CoV-2-Induced Vasculitic Skin Lesions Are Associated with Massive Spike Protein Depositions in Autophagosomes.SARS-CoV-2 诱导的血管炎性皮肤损伤与自噬体中大量刺突蛋白沉积有关。
J Invest Dermatol. 2024 Feb;144(2):369-377.e4. doi: 10.1016/j.jid.2023.07.018. Epub 2023 Aug 12.
10
Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).白细胞碎裂性血管炎作为 ChAdOx1 nCoV-19 冠状病毒疫苗(重组)的皮肤表现。
Dermatol Ther. 2021 Nov;34(6):e15141. doi: 10.1111/dth.15141. Epub 2021 Oct 5.

引用本文的文献

1
Cutaneous small vessel vasculitis in the COVID-19 era: a systematic review.新冠疫情时代的皮肤小血管血管炎:一项系统综述
Skin Health Dis. 2025 Apr 22;5(2):114-123. doi: 10.1093/skinhd/vzaf004. eCollection 2025 Apr.
2
Normocomplementemic Urticarial Vasculitis Following Influenza Vaccination: A Case Report and Review of the Literature.流感疫苗接种后补体正常的荨麻疹性血管炎:一例报告及文献复习
Int Med Case Rep J. 2024 Sep 28;17:823-829. doi: 10.2147/IMCRJ.S483023. eCollection 2024.
3
Onset of leukocytoclastic vasculitis following covid-19 vaccination: case based comprehensive review.

本文引用的文献

1
Pfizer-biontech COVID-19 RNA vaccination induces phosphatidylserine autoantibodies, cryoglobulinemia, and digital necrosis in a patient with pre-existing autoimmunity.辉瑞-生物科技公司的新冠病毒RNA疫苗在一名已有自身免疫性疾病的患者中诱发了磷脂酰丝氨酸自身抗体、冷球蛋白血症和手指坏死。
Clin Immunol Commun. 2021 Dec;1:1-3. doi: 10.1016/j.clicom.2021.08.001. Epub 2021 Sep 27.
2
Multisystem inflammatory syndrome after SARS-CoV-2 vaccination (MIS-V), to interpret with caution.2019冠状病毒病疫苗接种后多系统炎症综合征(MIS-V),需谨慎解读。
Postgrad Med J. 2022 Mar 1;98(e2):e91. doi: 10.1136/postgradmedj-2021-140869.
3
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience.
接种新冠疫苗后白细胞碎裂性血管炎的发病机制:基于病例的综合综述。
Rheumatol Int. 2024 Nov;44(11):2621-2635. doi: 10.1007/s00296-024-05718-x. Epub 2024 Sep 16.
4
COVID-19 vaccine-associated vasculitis: A systematic review.新型冠状病毒肺炎疫苗相关血管炎:一项系统评价
SAGE Open Med. 2024 Aug 30;12:20503121241261165. doi: 10.1177/20503121241261165. eCollection 2024.
5
Factors influencing the outcomes of dermatoses during the COVID-19 outbreak in China: a retrospective study.中国新冠疫情期间影响皮肤病结局的因素:一项回顾性研究
Front Med (Lausanne). 2024 May 30;11:1417358. doi: 10.3389/fmed.2024.1417358. eCollection 2024.
6
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.儿童、成人及弱势群体中的新冠长期症状:综合概述与综合应对方法
Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095.
7
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis.免疫介导性皮肤病患者中 COVID-19 疫苗的免疫原性、有效性和安全性:一项系统评价与荟萃分析
Acta Derm Venereol. 2024 May 2;104:adv40009. doi: 10.2340/actadv.v104.40009.
8
Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies.COVID-19 及基于 mRNA 疫苗接种后的自身 DNA 驱动炎症:对非 COVID-19 病理的启示。
Front Immunol. 2024 Feb 19;14:1259879. doi: 10.3389/fimmu.2023.1259879. eCollection 2023.
9
Learning from the Experiences in the COVID-19 Pandemic - Impact on Quality of Life and Challenges for the Staff of a Dermatological Hospital and Rehabilitation Center in Germany: A Retrospective Analysis.借鉴新冠疫情经验——对德国一家皮肤病医院及康复中心工作人员生活质量的影响与挑战:一项回顾性分析
Clin Cosmet Investig Dermatol. 2023 Nov 13;16:3279-3290. doi: 10.2147/CCID.S429065. eCollection 2023.
10
Herpes Zoster and COVID-19 Vaccination: A Narrative Review.带状疱疹与新冠病毒疫苗接种:一篇叙述性综述
Clin Cosmet Investig Dermatol. 2023 Nov 16;16:3323-3331. doi: 10.2147/CCID.S441898. eCollection 2023.
新型冠状病毒2型疫苗加强针接种后的皮肤不良反应:一项真实世界多中心经验
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e876-e879. doi: 10.1111/jdv.18386. Epub 2022 Jul 10.
4
Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review.接种 Ad26.COV2.S 疫苗后出现 COVID-19 皮肤白细胞碎裂性血管炎:病例报告及文献复习。
Acta Dermatovenerol Alp Pannonica Adriat. 2022 Jun;31(2):83-87.
5
Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases.接种 COVID-19 疫苗后的皮肤表现:25 例报告。
Dermatol Ther. 2022 Aug;35(8):e15651. doi: 10.1111/dth.15651. Epub 2022 Jul 4.
6
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis.COVID-19 相关小儿血管炎:系统综述及发病机制的详细分析。
Semin Arthritis Rheum. 2022 Aug;55:152047. doi: 10.1016/j.semarthrit.2022.152047. Epub 2022 Jun 9.
7
Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature.COVID-19 后血管炎发作:两名预先存在的 IgA 血管炎控制患者的病例报告及文献复习。
Rheumatol Int. 2022 Sep;42(9):1643-1652. doi: 10.1007/s00296-022-05153-w. Epub 2022 Jun 13.
8
COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports.COVID-19 与新发 IgA 血管炎:病例报告的系统回顾。
J Emerg Nurs. 2022 Jul;48(4):348-365. doi: 10.1016/j.jen.2022.05.002. Epub 2022 May 13.
9
A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination.接种 SARS-CoV-2 疫苗后发生白细胞碎裂性血管炎 1 例。
J Emerg Med. 2022 Aug;63(2):e62-e65. doi: 10.1016/j.jemermed.2021.10.005. Epub 2021 Oct 23.
10
COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement.COVID-19 疫苗相关多系统小血管血管炎。
Z Rheumatol. 2022 Aug;81(6):509-512. doi: 10.1007/s00393-022-01159-8. Epub 2022 May 19.